Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Dougan

Showing results (61-70 of 145) with videos related to

Pageof 15
Sort By:
Cancer Immunology Research|December 1, 2017
IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT CellsEleanor Clancy-Thompson, Lestat Ali, Patrick T Bruck, et al.
Current Oncology Reports|February 7, 2026
Utilization of Steroid Sparing Agents for Immune-Related Adverse Events (irAEs): Management Strategies and ConsiderationsSherin J Rouhani, Matthew J Hadfield, Matthew Lei, et al.
Immunotherapy Advances|July 22, 2021
Type 2 immunity is maintained during cancer-associated adipose tissue wastingPatrick J Lenehan, Assunta Cirella, Amiko M Uchida, et al.
Cancer Immunology Research|January 25, 2014
Transnuclear TRP1-specific CD8 T cells with high or low affinity TCRs show equivalent antitumor activityStephanie K Dougan, Michael Dougan, Jun Kim, et al.
Journal for Immunotherapy of Cancer|October 9, 2020
Diagnostic utility of CT for suspected immune checkpoint inhibitor enterocolitisSienna M Durbin, Meghan J Mooradian, Florian Johannes Fintelmann, et al.
Molecular Cancer Therapeutics|February 3, 2017
Clinical Dosing Regimen of Selinexor Maintains Normal Immune Homeostasis and T-cell Effector Function in Mice: Implications for Combination with ImmunotherapyPaul M Tyler, Mariah M Servos, Romy C de Vries, et al.
Journal for Immunotherapy of Cancer|May 17, 2020
Mucosal inflammation predicts response to systemic steroids in immune checkpoint inhibitor colitisMeghan J Mooradian, Daniel Y Wang, Alexandra Coromilas, et al.
Plos Pathogens|October 3, 2015
Disruption of Sphingolipid Biosynthesis Blocks Phagocytosis of Candida albicansFikadu G Tafesse, Ali Rashidfarrokhi, Florian I Schmidt, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2016
Durable antitumor responses to CD47 blockade require adaptive immune stimulationJonathan T Sockolosky, Michael Dougan, Jessica R Ingram, et al.
Cancer Medicine|July 10, 2019
Colitis after checkpoint blockade: A retrospective cohort study of melanoma patients requiring admission for symptom controlMichael S Hughes, Hui Zheng, Leyre Zubiri, et al.
Pageof 15

Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
Cancer Immunology Research|December 1, 2017
IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT CellsEleanor Clancy-Thompson, Lestat Ali, Patrick T Bruck, et al.
Current Oncology Reports|February 7, 2026
Utilization of Steroid Sparing Agents for Immune-Related Adverse Events (irAEs): Management Strategies and ConsiderationsSherin J Rouhani, Matthew J Hadfield, Matthew Lei, et al.
Immunotherapy Advances|July 22, 2021
Type 2 immunity is maintained during cancer-associated adipose tissue wastingPatrick J Lenehan, Assunta Cirella, Amiko M Uchida, et al.
Cancer Immunology Research|January 25, 2014
Transnuclear TRP1-specific CD8 T cells with high or low affinity TCRs show equivalent antitumor activityStephanie K Dougan, Michael Dougan, Jun Kim, et al.
Journal for Immunotherapy of Cancer|October 9, 2020
Diagnostic utility of CT for suspected immune checkpoint inhibitor enterocolitisSienna M Durbin, Meghan J Mooradian, Florian Johannes Fintelmann, et al.
Molecular Cancer Therapeutics|February 3, 2017
Clinical Dosing Regimen of Selinexor Maintains Normal Immune Homeostasis and T-cell Effector Function in Mice: Implications for Combination with ImmunotherapyPaul M Tyler, Mariah M Servos, Romy C de Vries, et al.
Journal for Immunotherapy of Cancer|May 17, 2020
Mucosal inflammation predicts response to systemic steroids in immune checkpoint inhibitor colitisMeghan J Mooradian, Daniel Y Wang, Alexandra Coromilas, et al.
Plos Pathogens|October 3, 2015
Disruption of Sphingolipid Biosynthesis Blocks Phagocytosis of Candida albicansFikadu G Tafesse, Ali Rashidfarrokhi, Florian I Schmidt, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2016
Durable antitumor responses to CD47 blockade require adaptive immune stimulationJonathan T Sockolosky, Michael Dougan, Jessica R Ingram, et al.
Cancer Medicine|July 10, 2019
Colitis after checkpoint blockade: A retrospective cohort study of melanoma patients requiring admission for symptom controlMichael S Hughes, Hui Zheng, Leyre Zubiri, et al.
Pageof 15